Site Search

Share

X

Search Results

ACS CAN calls on legislative leaders to include colorectal cancer screening in state budget

ALBANY, NY – A coalition of more than 65 patient and provider groups, cancer centers, and other public health organizations delivered a letter to state legislative leaders in support of legislation that would require insurance plans to cover ... stool-based screening test, it should be considered as the next step in the preventive screening process and therefore should be covered by health insurers with no patient out-of-pocket cost. ACS CAN is calling on state leaders to include S906-B sponsored by Senators Sanders and Kennedy ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...

Statement on the Death of Supreme Court Justice and Equal Rights Champion Ruth Bader Ginsburg

... with various forms of cancer including colon, lung and the recurrent pancreatic cancer that eventually claimed her life. However, her personal health history and active survivorship made her an inspiration for many patients and survivors and helped inform her deep commitment to public health policy. “Justice Ginsburg was one of six justices to uphold the Affordable Care Act, which has given cancer patients and survivors critical access to comprehensive health coverage, including cancer prevention, screening ...

Cancer Research Across Minnesota

... and clinical trial across Minnesota, and what researchers need to ensure all patients can equitably access the latest innovations in cancer care and treatment. Every new breakthrough in freeing the world from the pain and suffering of cancer - from new cures to innovative ways to ... prevent and treat the disease - have one thing in common; the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.  This virtual event will discuss Community Oncology Research Programs (NCORP), the impact that NIH and ... , Principal Investigator, Metro-Minnesota Community Oncology Research Consortium Bret E. Friday, Ph.D., M.D. , Principal Investigator, Essentia Health Community NCORP Preston D. Steen, M.D. , Principal Investigator, Sanford Community Cancer Program NCORP Kelly Leibold , ACS CAN Minnesota ...

Legislative Action Needed to Reduce the Burden of Cancer on Wyomingites

... postpartum.  “After giving birth, we know that cancer risks are heightened. Ensuring low-income individuals and families have affordable health coverage for a full year postpartum is one of the most critical ways to reduce cancer incidence and mortality,” said Kristin Page-Nei, the ... with the American Cancer Society Cancer Action Network. “Extending postpartum Medicaid coverage is a positive step toward improving the health outcomes of women and their children. Ultimately though, the most cost-effective solution to improve the lives of all Wyomingites – ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...

Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments

Sacramento, Calif. –  The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which was introduced by Senator ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “The advances in cancer treatment that have come ... from being able to tailor approaches to a person’s individual condition are critical for winning the fight against cancer and helping reduce health disparities,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the ...

Dr. David O. Garcia Named to American Cancer Society Cancer Action Network’s National Board of Directors

... and guidance for ACS CAN, which pursues evidence-based public policy and legislative solutions designed to eliminate cancer as a major health problem nationwide. His term begins on Jan. 1, 2022. Headquartered in Washington, D.C., ACS CAN mobilizes grassroots volunteers across the ... lives through support for cancer research, prevention and treatments.  “As demonstrated by his extensive experience and knowledge in public health and preventable disease, Dr. Garcia will bring a critical perspective when he begins his term on ACS CAN’s Board,” said ACS CAN ... serve in this role. There are significant health inequities present in communities driven by social determinants of health, including access to care. I hope to help others understand how these factors impact cancer prevention and treatment efforts, particularly for underserved ...

Governor Ducey Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments

... life enhancing tool,” said Michael, from Tucson. “Biomarker testing and precision medicine are helping extend and save lives by tailoring care and treatment to a person’s individual disease,” said Brian Hummell, government relations director for the American Cancer Society Cancer ... of cancer clinical trials that involve biomarkers has grown significantly.” Despite its benefits and increasingly important role in cancer care, access to biomarker testing has not kept pace with the rate of innovation and advancements in treatment. One significant barrier for patients is lack of coverage by private health insurance and Medicaid programs for appropriate testing. Currently, communities that have been under-resourced, including communities of ...

Racial Injustice and a Commitment to Be Part of the Solution

... that ACS CAN continues to actively engage in conversations that are critical to addressing the issues of racial injustice that have driven health inequality in this country. We cannot shy away from tough conversations - not when lives are at stake.  Systemic racism is a public health issue and our only hope for addressing the cancer burden in a just and equitable way is to fight for public policy solutions that aim at the root causes that undermine access to care for communities of color. We must stand together and partner with individuals and organizations that have been on the front lines fighting for ...

Hundreds of Cancer Patients, Survivors Travel to D.C. Urging Congress to Make Cancer a National Priority

... down barriers to coverage for lifesaving screenings for those at highest risk of prostate cancer is key to beginning to close the gap on health disparities in our country, particularly as prostate cancer continues to be the leading cause of cancer death for Black men,” said Lisa ... whether an individual is able to remain up to date on their recommended cancer screenings. The PSA Screening for HIM Act would improve health outcomes for our loved ones and neighbors most at-risk by removing out-of-pocket costs for prostate cancer screenings.”  Volunteers will ... of K&L Gates for their efforts leading ACS CAN and other public health groups in preserving critical patient protections under the Affordable Care Act. Adam S. Cooper, Gretchen P. Mahoney, and Beth W. Petronio led the charge to protect access to lifesaving preventive care in the case of ...

Addressing Health Disparities in Clinical Trials

Addressing Health Disparities in Clinical Trials Presented by AstraZeneca and the American Cancer Society Cancer Action Network Tuesday, November 10th 9 AM to ... Accendo Panelists: Dr. Christopher Lathan Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center Director, Cancer Care Equity Program Assistant Professor of Medicine, Harvard Medical School Dr. Pandy Opima Clinical Trial Diversity Lead, CMO Office, AstraZeneca ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy